SION SIONNA THERAPEUTICS INC revenue, earnings and financials
For the quarter ended June 30, 2026, SIONNA THERAPEUTICS INC reported revenue of n/a, net income of −$29.9M and diluted EPS of −$0.66; for the fiscal year ended December 2025 revenue was n/a.
SION annual revenue and earnings
- Fiscal year ended Dec 2025: revenue n/a, gross profit n/a, operating income −$89.0M, net income −$75.3M (margin n/a), EPS −$1.88
- Fiscal year ended Dec 2024: revenue n/a, gross profit n/a, operating income −$70.6M, net income −$61.7M (margin n/a), EPS −$15.99
SION quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$29.9M, EPS −$0.66
- Quarter ended Mar 31, 2026: revenue n/a, net income −$26.8M, EPS −$0.60
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income −$20.4M, EPS −$0.39
- Quarter ended Sep 30, 2025: revenue n/a, net income −$20.3M, EPS −$0.46
- Quarter ended Jun 30, 2025: revenue n/a, net income −$18.1M, EPS −$0.41
- Quarter ended Mar 31, 2025: revenue n/a, net income −$16.5M, EPS −$0.62
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income −$15.8M, EPS $6539.68
- Quarter ended Sep 30, 2024: revenue n/a, net income −$25.4M, EPS −$5.67
- Quarter ended Jun 30, 2024: revenue n/a, net income −$8.55M, EPS −$2710.00
- Quarter ended Mar 31, 2024: revenue n/a, net income −$11.8M, EPS −$3840.00
SION cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$66.3M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$52.8M, share buybacks n/a
SION balance sheet
- Jun 30, 2026: cash $63.3M, total assets $283M, total liabilities $17.5M, shareholders' equity $266M
- Mar 31, 2026: cash $63.3M, total assets $305M, total liabilities $16.8M, shareholders' equity $288M
- Dec 31, 2025: cash $58.5M, total assets $326M, total liabilities $19.1M, shareholders' equity $307M
- Sep 30, 2025: cash $50.8M, total assets $339M, total liabilities $17.6M, shareholders' equity $322M
- Jun 30, 2025: cash $41.0M, total assets $352M, total liabilities $15.6M, shareholders' equity $336M
- Mar 31, 2025: cash $82.7M, total assets $370M, total liabilities $17.9M, shareholders' equity $352M
- Dec 31, 2024: cash $37.8M, total assets $186M, total liabilities $19.1M, shareholders' equity −$164M
Is SION profitable?
No. SIONNA THERAPEUTICS INC lost $97.4M over the last four quarters.
What is SION's EPS?
Diluted earnings per share over the last four quarters were −$2.11; −$0.66 in the latest quarter.